SG Americas Securities, LLC - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 40 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q4 2019$551,000
+5.6%
5,0600.0%0.01%
+25.0%
Q3 2019$522,000
-8.3%
5,0600.0%0.00%0.0%
Q2 2019$569,000
-1.2%
5,0600.0%0.00%
-20.0%
Q1 2019$576,000
+2.1%
5,0600.0%0.01%0.0%
Q4 2018$564,000
-7.5%
5,0600.0%0.01%0.0%
Q3 2018$610,000
+1.3%
5,0600.0%0.01%0.0%
Q2 2018$602,000
+7.5%
5,0600.0%0.01%
+25.0%
Q1 2018$560,000
-7.9%
5,0600.0%0.00%
-20.0%
Q3 2017$608,000
-27.9%
5,060
-28.3%
0.01%
-37.5%
Q2 2017$843,000
+0.7%
7,0600.0%0.01%
+14.3%
Q1 2017$837,000
+0.7%
7,0600.0%0.01%0.0%
Q4 2016$831,000
-6.0%
7,0600.0%0.01%
-22.2%
Q3 2016$884,000
-36.9%
7,060
-41.5%
0.01%
-10.0%
Q2 2016$1,400,000
-2.5%
12,0600.0%0.01%0.0%
Q1 2016$1,436,000
-11.2%
12,0600.0%0.01%
-9.1%
Q4 2015$1,618,00012,0600.01%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q1 2019
NameSharesValueWeighting ↓
Birch Grove Capital LP 5,000,000$5,003,0002.71%
Weiss Asset Management LP 65,841,000$64,360,0002.62%
Davide Leone & Partners Investment Co Ltd. 10,500,000$10,513,0001.19%
TENOR CAPITAL MANAGEMENT Co., L.P. 29,597,000$29,800,0001.14%
GLAZER CAPITAL, LLC 7,483,000$7,474,0000.36%
BLUEFIN CAPITAL MANAGEMENT, LLC 52,500$5,243,0000.33%
OAKTREE CAPITAL MANAGEMENT LP 13,428,000$13,444,0000.29%
CSS LLC/IL 5,500,000$5,498,0000.26%
Kohlberg Kravis Roberts & Co. L.P. 40,182,000$40,159,0000.23%
EDMOND DE ROTHSCHILD HOLDING S.A. 2,606,000$2,606,0000.10%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders